DJIA 17,279.74 13.75 0.08%
NASDAQ 4,579.79 -13.64 -0.30%
S&P 500 2,010.40 -0.96 -0.05%
market minute promo

Nektar Therapeutics (NASDAQ: NKTR)

12.82 -0.54 (-4.04%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NKTR $12.82 -4.04%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $13.40
Previous Close $13.36
Daily Range $12.82 - $13.49
52-Week Range $8.87 - $15.34
Market Cap $1.6B
P/E Ratio -11.32
Dividend (Yield) $0.00 (0.0%)
Volume 2,722,504
Average Daily Volume 1,133,338
Current FY EPS -$0.65

Sector

Healthcare

Industry

Drugs

Nektar Therapeutics (NKTR) Description

A biopharmaceutical company which develops breakthrough products that make a difference in patients' lives. It creates differentiated, innovative products by applying its platform technologies to established or novel medicines. Website: http://www.nektar.com/

News & Commentary Rss Feed

Can Anything Derail Salix Pharmaceuticals?

Expanded labeling for the sub-q form of Relistor could add $100 million in revenue, but doesn't change the business to a large extent

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Salix' s Xifaxan 550 sNDA Under Review, Response by Feb 28 - Analyst Blog

Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 20

Nektar Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 2014 American Academy Of Pain Management Meeting

AstraZeneca's Constipation Drug Movantik Gets FDA Nod - Analyst Blog

How Will AstraZeneca (AZN) and Nektar Therapeutics (NKTR) Stock Reacy to FDA's Movantik Approval?

Nektar 181 Could Dominate A $13B Chronic Pain Market

Monday's ETF Movers: FBT, GDX

Positive Data on Baxter's Trial for BAX 855 - Analyst Blog

Positive Data on Baxter's Trial for BAX 855 - Analyst Blog

Nektar Therapeutics Has More To Give

Nektar Therapeutics Harnesses The Power Of AstraZeneca To Move Movantik

Nektar President Howard Robin Is Listening To You

See More NKTR News...

NKTR's Top Competitors

NKTR $12.82 (-4.04%)
Current stock: NKTR
TMO $123.24 (-0.72%)
Current stock: TMO
ILMN $172.26 (-3.18%)
Current stock: ILMN
WAT $101.58 (-0.54%)
Current stock: WAT